DYNAMICS OF ANTHRACYCLINES/DNA INTERACTION: A LASER TIME‐RESOLVED FLUORESCENCE STUDY *
暂无分享,去创建一个
[1] M. Bertolaccini,et al. The logic design of high precision time-to-pulse-height converters: Part II. A converter design based on the use of integrated circuits , 1974 .
[2] F. Zunino,et al. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives. , 1976, Cancer research.
[3] G. L. Tong,et al. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline. , 1979, Journal of medicinal chemistry.
[4] G. L. Tong,et al. Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin. , 1981, Journal of medicinal chemistry.
[5] Sequence specificity in DNA for the interaction with adriamycin or daunomycin. , 1982, Il Farmaco; edizione scientifica.
[6] D. Crothers,et al. Self-association of daunomycin. , 1982, Biochemistry.
[7] F. Zunino,et al. Influence of some chromophore substituents on the intercalation of anthracycline antibiotics into DNA , 1982 .
[8] E. Acton,et al. Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects. , 1982, Biochemical pharmacology.
[9] R. Catterall,et al. Beyond Chi-Square: Evaluation of Parametric Models Used in the Analysis of Data from Fluorescence Decay Experiments , 1983 .
[10] V. Malatesta,et al. Electrochemical deglycosidation of anthracyclines: stereoelectronic requirements , 1984 .
[11] D. Crothers,et al. Kinetics of the daunomycin--DNA interaction. , 1985, Biochemistry.
[12] V. Malatesta,et al. Chelation of copper(II) ions by doxorubicin and 4'-epidoxorubicin: an e.s.r. study. , 1985, Anti-cancer drug design.
[13] J. Smith,et al. Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].poly[d(G-C)], and poly[d(A-T)].poly[d(A-T)]. , 1986, Biochemistry.
[14] V. Malatesta,et al. A molecular mechanics study of the intramolecular conformational equilibrium in doxorubicin and 4'-epidoxorubicin , 1986 .
[15] J. González-Ros,et al. Interaction of anthracyclines with nucleotides and related compounds studied by spectroscopy. , 1986, Biochimica et biophysica acta.
[16] J. Smith,et al. Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly[d(G-C)].cntdot.poly[d(G-C)], and poly[d(A-T)].cntdot.poly[d(A-T)] , 1986 .
[17] V. Malatesta,et al. Quantum mechanical prediction of the conformational preferences of daunomycins and their relationship to reactivity , 1986 .
[18] Anthracycline-copper(II) complexes: Structure-dependent coordination pattern as evidenced by ESR , 1987 .
[19] V. Malatesta,et al. Chelation of copper(II) ions by doxorubicin and 4′-epidoxorubicin: ESR evidence for a new complex at high anthracycline/copper molar ratios , 1987 .
[20] Redox Properties of Antitumor Anthracyclines as Predicted from ab initio Calculations and Electrochemical Experiments , 1987 .
[21] The interaction between superoxide dismutase and doxorubicin. An electron spin resonance approach , 1987 .
[22] Imino derivatives of anthracyclines: Electronic properties, relative stabilities relationship to activity , 1987 .
[23] Redox properties of antitumour anthracyclines as predicted from ab initio calculations and electrochemical experiments , 1987 .